Acute Obstructive Anural after an Allograft Kidney Biopsy: An Unusual Complication

2021 ◽  
Vol 04 (01) ◽  
Author(s):  
Rida Touab ◽  
Youness Khdach ◽  
Mohammed R Andaloussi ◽  
Larbi Hamdoune ◽  
Abderrahmene Elwali ◽  
...  
1998 ◽  
Vol 65 (6) ◽  
pp. 911-913 ◽  
Author(s):  
Amita Trehan ◽  
Deepak Takhtani ◽  
Surjit Singh ◽  
Lata Kumar

2014 ◽  
Vol 142 (suppl_1) ◽  
pp. A264-A264
Author(s):  
Ellen Flatley ◽  
Gerald Segal ◽  
Thomas Batiuk ◽  
William Bennett ◽  
Donald Houghton ◽  
...  

Heliyon ◽  
2021 ◽  
pp. e07189
Author(s):  
Wichien Sirithanaphol ◽  
Natthida Incharoen ◽  
Ukrit Rompsaithong ◽  
Pakorn Kiatsopit ◽  
Supanut Lumbiganon ◽  
...  

2021 ◽  
pp. 55-62
Author(s):  
Panupong Hansrivijit ◽  
Kinjal P. Gadhiya ◽  
Sandra D. Zelonis ◽  
John T. Cinicola

Late-onset retroperitoneal hemorrhage from renal intraparenchymal pseudoaneurysm (RIP) following a kidney biopsy is an extremely rare complication but should not be ignored, especially in high-risk populations. Here, we introduce a 32-year-old Caucasian female who presented with sudden-onset left-sided flank pain. She had recently been diagnosed with systemic lupus erythematosus (SLE) and had undergone a computed tomography (CT)-guided core needle biopsy of the left kidney 9 days earlier. The results were consistent with lupus nephritis class III or IV. Initial vitals were within normal limits. She appeared pale and her left flank was tender to palpation without discoloration or abdominal distention. Laboratory investigations showed a hemoglobin level of 7.1 g/dL. The CT scan of the abdomen and pelvis revealed a large hyperdense left perinephric collection consistent with perinephric hematoma with a moderate amount of retroperitoneal stranding most prominent on the left side extending across the midline to the right side. Contrast extravasation was suspected in the lower pole of the left kidney consistent with active bleeding site. Emergent renal angiography revealed a 2 × 1 cm intraparenchymal pseudoaneurysm in the lower pole of the left kidney along with a few small microaneurysms. Coil embolization of the pseudoaneurysm was successfully performed without any complications. In conclusion, SLE or lupus nephritis in this patient may be the predisposing factors for microaneurysm and RIP formations. RIP is an unusual complication after percutaneous kidney biopsy that carries a significant mortality rate if ruptured, causing retroperitoneal hemorrhage. Clinicians should be vigilant when encountering high-risk patients with persistent hematuria, flank pain, or abdominal pain within four weeks after a kidney biopsy.


2019 ◽  
Vol 12 (1) ◽  
Author(s):  
Zijie Wang ◽  
Zili Lyu ◽  
Ling Pan ◽  
Gang Zeng ◽  
Parmjeet Randhawa

2020 ◽  
Author(s):  
Hemant Suryawanshi ◽  
Hua Yang ◽  
Michelle Lubetzky ◽  
Pavel Morozov ◽  
Mila Lagman ◽  
...  

AbstractBackgroundSingle-cell RNA-sequencing (scRNA-seq) provides unique opportunity to study cell types and cell states at a hitherto unavailable level of precision. We tested the hypothesis that scRNA-seq and computational analysis of human kidney allograft biopsies will reveal new cell types and cell states and yield insights to personalize the care of transplant recipients.MethodsWe selected 3 kidney biopsies from 3 individuals for scRNA-seq using the 10x Chromium Single Cell platform; (i) HK: native kidney biopsy from a living kidney, (ii) AK1: allograft kidney biopsy with transplant glomerulopathy, fibrosis, and worsening kidney function but with undetectable circulating anti-HLA antibodies, and (iii) AK2: allograft kidney biopsy after successful treatment of active antibody-mediated rejection but with persistent circulating donor-specific anti-HLA antibodies.ResultsWe generated 7,217 high-quality single cell transcriptomes. Taking advantage of the recipient-donor sex mismatches, we determined that in the AK1 biopsy with fibrosis, more than half of the kidney allograft fibroblasts were—unexpectedly—recipient-derived and therefore likely migratory and graft infiltrative, whereas in the AK2 biopsy without fibrosis, all the fibroblasts were donor-derived. Furthermore, tubular progenitor cells that overexpress profibrotic extracellular matrix genes potentially contributing to fibrosis, were enriched in AK1 biopsy. Eight months after successful treatment of antibody-mediated rejection, AK2 biopsy contained endothelial cells that expressed mRNA for T-cell chemoattractant cytokines. In addition to these key findings, our analysis revealed unique cell types and cell states in the kidney.ConclusionsAltogether, single cell transcriptomics complemented histopathology and yielded novel mechanistic insights for individualizing the care of transplant recipients.


1993 ◽  
Vol 70 (05) ◽  
pp. 730-735 ◽  
Author(s):  
P Toulon ◽  
M Lamine ◽  
I Ledjev ◽  
T Guez ◽  
M E Holleman ◽  
...  

SummaryIn human plasma, heparin cofactor II (HCII) is a thrombin inhibitor, whose deficiency has been reported to be associated with recurrent thrombosis. The finding of two cases of low plasma HCII activity in two patients infected with the human immunodeficiency virus (HIV) led us to investigate this coagulation inhibitor in the plasma of a larger population of HIV-infected patients. The mean plasma HCII activity was significantly lower in 96 HIV-infected patients than in 96 age- and sex-matched healthy individuals (0.75 ± 0.24 vs 0.99 ± 0.17 U/ml, p <0.0001). HCII antigen concentration was decreased to the same extent as the activity. The proportion of subjects with HCII deficiency was significantly higher in the HIV-infected group than in healthy individuals (38.5% vs 2.1%). In addition, HCII was significantly lower in AIDS patients than in other HIV-infected patients, classified according to the Centers for Disease Control (CDC) on the basis of an absolute number of circulating CD4+ lymphocytes below 200 x 106/1. The link between HCII and immunodeficiency is further suggested by significant correlations between HCII activity and both the absolute number of CD4+ lymphocytes and the CD4+ to CD8+ lymphocyte ratio. Nevertheless, the mean HCII level was not different in the various groups of patients classified according to clinical criteria, except in CDC IVD patients in whom HCII levels were significantly lower. In addition, no correlation could be demonstrated between HCII and protein S activities, another coagulation inhibitor whose plasma level was also found to be decreased in HIV-infected patients. A similar prevalence of HCII deficiency was also found in a small series of 7 HIV-infected patients who developed thrombotic episodes, an unusual complication of the infection. This suggests that, in HIV-infected patients, HCII deficiency is not in itself the causative factor for the development of thrombosis.


Sign in / Sign up

Export Citation Format

Share Document